Biofarm Board of Directors on Monday published the official position about the voluntary tender offer launched by Polish group Zakłady Farmaceutyczne Polpharma S.A, supporting the deal and explaining to the minority shareholders what will happen with the issuer once it is no longer controlled by current shareholders.